CD5024 0.3% Cream

· Galderma R&D

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD5024 0.3% Cream, covering 2023-05-01 to 2023-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis [Phase 2]